Dr. Ian Lewis, Novartis Pharmaceuticals, CH
«SOM230: A new therapeutic modality for Cushing’s disease»
Start Date
02.12.2014 - 17:00
Event End
02.12.2014 - 18:30
Location
Universität Zürich, Campus Irchel, Departement für Chemie
«SOM230: A new therapeutic modality for Cushing’s disease»